Medical Affairs and Clinical Research
BBCR offers expertise in the areas of Product Development Planning and Validation or Qualification when biomarkers are a component of your product development plan.
August 3rd, 2022 | Medical Affairs and Clinical ResearchWe are pleased to announce that BBCR Consulting President, Candida Fratazzi, MD will be the keynote speaker at the upcoming 9th Clinical Trials Strategic Summit happening in San Francisco on October 27th and 28th, 2022
July 29th, 2022 | Medical Affairs and Clinical Research
BBCR is looking forward to attending this important event and expresses gratitude to Agile Falcon Strategic Group LLC for the opportunity to be a part of the upcoming Summit. The 9th Clinical Trials Strategic Summit (CTSS) will be taking place in San Francisco October 27th and 28th, 2022. We hope to see you there!
BBCR specializes in rare disease, working with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process in order to achieve optimal product market positioning.
July 27th, 2022 | Medical Affairs and Clinical Research
Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Click the button below to learn more about how we have helped companies with their clinical trial needs.
BBCR can help medical device companies with clinical data strategy from conception to market, from preparing due-diligence ready datasets for funders to post-marketing safety surveillance for regulatory authorities.
July 6th, 2022 | Medical Affairs and Clinical Research
Medical devices have their own special complications as it relates to clinical trials. We work closely with each client to bring device innovation to market faster and more affordably. Working with the BBCR team will help that streamlines clinical trials and help you get through the process faster and more efficiently. BBCR consulting offers the […]
In an ever-changing regulatory environment, the BBCR team of specialists in Orphan and Personalized Medicine can help clients identify areas of need or economic interest – and helps secure opportunities for treatments for rare diseases and precision medicine.
June 6th, 2022 | Medical Affairs and Clinical Research
BBCR helps orphan drug developers find direction in clinical trials involving biologics, biosimilars, small molecules, medical devices, and repurposing. BBCR consultants have the experience to guide you through the development process with a clinical plan and a regulatory strategy. Our team will empower you with medical insight, effective regulatory expertise, strategy, and streamlined early clinical […]
Streamlining clinical development with clinical and regulatory expertise is the cornerstone of our business. BBCR’s mission is to streamline your clinical development while reducing costs and improving safety.
May 24th, 2022 | Medical Affairs and Clinical Research
BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed to maximize time efficiencies, risk mitigation, and cost savings. Innovating the process of drug development with clinical and regulatory expertise is the central value of our business. BBCR’s mission […]
BBCR embraces innovative strategy consulting for highly effective clinical development plan and regulatory strategy. Reach out today to learn more about how we can help advance your project.
May 18th, 2022 | Medical Affairs and Clinical Research
Our industry needs innovative strategies, and reduced-risk clinical trials. BBCR clinical development services and drug development consulting integrates real world evidence into clinical development plans and regulatory strategies. We ensure that focus goes towards cost containment and value-based developments that allow sponsors to move more treatments to market faster. BBCR’s team expertise in rare diseases […]
Boston Biotech Clinical Research specializes in rare disease, working with biotech, pharmaceutical, investors and device companies to help streamline the clinical trial process.
May 11th, 2022 | Medical Affairs and Clinical Research
Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed […]
BBCR’s team of experts help clients match treatments to rare genetic conditions and unsolved diseases, then work cohesively with a product developer on the best plan to market.
May 4th, 2022 | Medical Affairs and Clinical Research
Did you know that about a third of orphan approvals by the FDA since the program began have been mostly for repurposed mass-market drugs? Drug repurposing acts to lower the need for early stage clinical trials and can help identify new uses for existing drugs. We invite you to learn more about how BBCR can […]
BBCR’s team of experts help to streamline clinical development strategies for biotech companies, venture capitalists, investors, research organizations and pharmaceutical companies.
April 26th, 2022 | Medical Affairs and Clinical Research
Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. BBCR’s medical experts optimize development strategies for biotech companies, venture capitalists, investors, research organizations and pharmaceutical companies. At BBCR Consulting, our team specializes in rare disease […]